Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins

British Journal of Pharmacology

Volumn 122, Issue 6, 1997, Pages 975-984

  Heinemann, Akos ^a   Wachter, Christof H ^a   Peskar, Bernhard A ^a   Holzer, Peter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Angiotensin AT1 receptor antagonist; Angiotensin II; Arginine vasopressin; Blood flow; Femoral artery; Nitric oxide; Prostaglandins

Indexed keywords

ANGIOTENSIN; ARGIPRESSIN; BOSENTAN; ENDOTHELIN RECEPTOR; HEXAMETHONIUM; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PRAZOSIN; PROPRANOLOL; PROSTAGLANDIN; TELMISARTAN; URETHAN;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTERY DILATATION; ARTICLE; BOLUS INJECTION; CONDUCTANCE; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FEMORAL ARTERY FLOW; GRAVITY; HEMODYNAMICS; HYPEREMIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; RESERVOIR; SUPERIOR MESENTERIC ARTERY; ULTRASOUND; VASOCONSTRICTION; VASODILATATION;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; FEMALE; FEMORAL ARTERY; HEXAMETHONIUM; INDOMETHACIN; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PRAZOSIN; PROPRANOLOL; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SULFONAMIDES; VASODILATION;

EID: 0030831908     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701460     Document Type: Article

References (55)

1. ANDERSON, E.A. & MARK, A.L. (1989). Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation, 79, 93-100.
2. BALAKRISHNAN, S.M., WANG, H.D., GOPALAKRISHNAN, V., WILSON, T.W. & McNEILL, J.R. (1996). Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension, 28, 806-809.
3. BARKER, J.E., BAKHLE, Y.S., ANDERSON, J., TREASURE, T. & PIPER, P.J. (1996). Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein. Br. J. Pharmacol., 118, 643-648.
4. BARNES, R.J., COMLINE, R.S., DOBSON, A. & DROST, C.J. (1983). An implantable transit time ultrasonic blood flow meter. J. Physiol., 345, 2P-3P.
5. BURTON, R.G. & GOREWIT, R.C. (1984). Ultrasonic flowmeter uses wide beam transit-time technique. Med. Electron., 15, 68-73.
6. CALDICOTT, W.J., TAUB, K.J. & HOLLENBERG, N.K. (1997). Identical mesenteric, femoral and renal vascular responses to angiotensin II and III in the dog. Life Sci., 20, 517-521.
7. CELLER, B.G. & SCHRAMM, L.P. (1981). Pre- and postganglionic sympathetic activity in splanchnic nerves of rats. Am. J. Physiol., 241, R55-R61.
8. CHIBA, S. & TSUKADA, M. (1992). Potent antagonistic action of OPC-31260, a vasopressin V2 receptor antagonist, on [Arg8]vasopressin-induced vasoconstriction in isolated simian femoral arteries. Eur. J. Pharmacol., 221, 393-395.
9. CLOZEL, M., BREU, V., GRAY, G.A., KALINA, B., LÖFFLER, B.-M., BURRI, K., CASSAL, J.-M., HIRTH, G., MÜLLER, M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
10. CORDER, R., LOWRY, P.J., WILKINSON, S.J. & RAMAGE, A.G. (1986). Comparison of the haemodynamic actions of neuropeptide Y, angiotensin II and noradrenaline in anaesthetised cats. Eur. J. Pharmacol., 121, 25-30.
11. COSENTINO, F., SILL, J.C. & KATUSIC, Z.S. (1993). Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery. Am. J. Physiol., 264, H413-H418.
12. CRISSINGER, K.D., KVIETYS, P.R. & GRANGER, D.N. (1988). Autoregulatory escape from norepinephrine infusion: roles of adenosine and histamine. Am. J. Physiol., 254, G560-G565.
13. D'ALMEIDA, M.S., GAUDIN C. & LEBREC, D. (1995). Validation of 1-and 2-mm transit time ultrasound flow probes on mesenteric artery and aorta. Am. J. Physiol., 268, H1368-H1372.
14. DEMBINSKA-KIEC, A., PALLAPIES, D., SIMMET, T., PESKAR, B.M. & PESKAR, B.A. (1991). Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection. Br. J. Pharmacol., 104, 811-816.
15. DONI, M.G., WHITTLE, B.J.R., PALMER, R.M.J. & MONCADA, S. (1988). Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur. J. Pharmacol., 151, 19-25.
16. DREXLER, H., ZEIHER, A.M., WOLLSCHLAGER, H., MEINERTZ, T., JUST, H. & BONZEL, T. (1989). Flow-dependent coronary artery dilatation in humans. Circulation, 80, 466-474.
17. FOZARD, J.R. & PART, M.L. (1992). The role of nitric oxide in the regional vasodilator effects of endothelin-1 in the rat. Br. J. Pharmacol., 105, 744-750.
18. B-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats. Br. J. Pharmacol., 112, 823-830.
19. GASIC, S., HEINZ, G. & KLEINBLOESEM, C. (1990). Quantitative evidence of peripheral conversion of angiotensin within the human leg: effects of local angiotensin-I administration and angiotensin-converting enzyme inhibition on regional blood flow and angiotensin-II balance across the leg. Naunyn Schmiedeberg's Arch. Pharmacol., 342, 436-440.
20. GRIFFITH, T.M., EDWARDS, D.H., DAVIES, R.L., HARRISON, T.J. & EVANS, K.T. (1987). EDRF coordinates the behaviour of vascular resistance vessels. Nature, 329, 442-445.
21. HABERL, R.L., DECKER, P.J. & EINHAUPL, K.M. (1991). Angiotensin degradation products mediate endothelium-dependent dilatation of rabbit brain arterioles. Circ. Res., 68, 1621-1627.
22. HAINSWORTH, R., KARIM, F. & STOKER, J.B. (1974). Blockade of peripheral vascular responses to isoprenaline by three beta-adrenoceptor antagonists in the anaesthetized dog. Br. J. Pharmacol., 51, 161-168.
23. HECKER, M., MÜLSCH, A., BASSENGE, E. & BUSSE, R. (1993). Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am. J. Physiol., 265, H828-H833.
24. HELLEBREKERS, L.J., LIARD, J.F., LABORDE, A.L., GREENE, A.S. & COWLEY, A.W. Jr. (1990). Regional autoregulatory responses during infusion of vasoconstrictor agents in conscious dogs. Am. J. Physiol., 259, H1270-H1277.
25. HOLTZ, J., FÖRSTERMANN, U., POHL, U., GIESLER, M. & BASSENGE, E. (1984). Flow-dependent, endothelium-mediated dilatation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. J. Cadiovasc. Pharmacol., 6, 1161-1169.
26. IKEO, T., YABANA, H., KUROSAWA, H., KABURAKI, M., KIKKAWA, K., NARITA, H., MURATA, S. & YAMAGUCHI, I. (1992). Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-[N-((1S)-1-carboxy-3-phenyl-propyl)amino]propionyl)-1-methyl-2- oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs. Arzneimittelforschung, 42, 1109-1114.
27. INGLES, A.C., RUIZ, F.J., SALOM, M.G., QUESADA, T. & CARBONELL, L.F. (1995). Role of nitric oxide and prostaglandins in the regulation of blood pressure in conscious rats. Can. J. Physiol. Pharmacol., 73, 693-698.
28. JOANNIDES, R., HAEFELI, W.E., LINDER, L., RICHARD, V., BAKKALI, E.H., THUILLEZ, C. & LUSCHER, T.F. (1995). Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation, 91, 1314-1319.
29. JOHNSON, J.A. & DAVIS, J.O. (1973). Angiotensin. II. Important role in the maintenance of arterial blood pressure. Science, 179, 906-907.
30. JUUL, B., AALKJAER, C. & MULVANY, M.J. (1987). Responses of femoral resistance vessels to angiotensin in vitro. Eur. J. Pharmacol., 135, 61-68.
31. KATUSIC, Z.S., SHEPHERD, J.T. & VANHOUTTE, P.M. (1984). Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ. Res., 55, 575-579.
32. KOLLER, A., SUN, D., HUANG, A. & KALEY, G. (1994). Corelease of nitric oxide and prostaglandins mediates flow-dependent dilatation of rat gracilis muscle arterioles. Am. J. Physiol., 267, H326-H332.
33. KOLLER, A., SUN, D. & KALEY, G. (1993). Role of shear stress and endothelial protaglandins in flow- and viscosity-induced dilatation of arterioles in vitro. Circ. Res., 72, 1276-1284.
34. KUO, L., CHILIAN, W.M. & DAVIS, M.J. (1991). Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am. J. Physiol., 261, H1706-H1715.
35. LAMONTAGNE, D., POHL, U. & BUSSE, R. (1992). Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ. Res., 70, 123-130.
36. LAMPING, K.G. & DOLE, W.P. (1988). Flow-mediated dilatation attenuates constriction of large coronary arteries to serotonin. Am. J. Physiol., 255, H1317-H1324.
37. LI, T. & ZIMMERMAN, B.G. (1990). In vivo comparison of renal and femoral vascular sensitivity and local angiotensin generation. Hypertension, 15, 204-209.
38. MAKTABI, M.A., TODD, M.M. & STACHOVIC, G. (1995). Angiotensin II contributes to cerebral vasodilatation during hypoxia in the rabbit. Stroke, 26, 1871-1876.
39. MARTINEZ, M.C., VILA, J.M., ALDASORO, M., MEDINA, P., FLOR, B. & LLUCH, S. (1994). Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin. Br. J. Pharmacol., 113, 419-424.
40. METTING, P.J., STEIN, P.M., STOOS, B.A., KOSTRZEWSKI, K.A. & BRITTON, S.L. (1989). Systemic vascular autoregulation amplifies pressor responses to vasoconstrictor agents. Am. J. Physiol., 256, R98-R105.
41. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
42. MONOS, E., COX, R.H. & PETERSON, L.H. (1978). Direct effect of physiological doses of arginine vasopressin on the arterial wall in vivo. Am. J. Physiol., 234, H167-H172.
43. MYERS, S.I. & HERNANDEZ, M.S. (1992). Oxygen free radical regulation of rat splanchnic blood flow. Surgery, 112, 347-354.
44. POHL, U., HERLAN, K., HUANG, A. & BASSENGE, E. (1991). EDRF-mediated shear-induced dilatation opposes myogenic vasoconstriction in small rabbit arteries. Am. J. Physiol., 261, H2016-H2023.
45. POHL, U., HOLTZ, J., BUSSE, R. & BASSENGE, E. (1986). Crucial role of the endothelium in the vasodilator response to increased flow. Hypertension, 8, 37-44.
46. PURDY, R.E. & WEBER, M.A. (1988). Angiotensin II amplification of alpha-adrenergic vasoconstriction: role of receptor reserve. Circ. Res., 63, 748-757.
47. REMAK, G., HOTTENSTEIN, O.D. & JACOBSON, E.D. (1990). Sensory nerves mediate neurogenic escape in rat gut. Am. J. Physiol., 258, H778-H786.
48. RUDICHENKO, V.M. & BEIERWALTES, W.H. (1995). Arginine vasopressin-induced renal vasodilatation mediated by nitric oxide. J. Vasc. Res., 32, 100-105.
49. SAI, Y., OKAMURA, T., AMAKATA, Y. & TODA, N. (1995). Comparison of responses of canine pulmonary artery and vein to angiotensin II, bradykinin and vasopressin. Eur. J. Pharmacol., 282, 253-241.
50. SINOWAY, L.I., HENDRICKSON, C., DAVIDSON, W.R. Jr., PROPHET, S. & ZELIS, R. (1989). Characteristics of flow-mediated brachial artery vasodilatation in human subjects. Circ. Res., 64, 32-42.
51. SUZUKI, S., TAKESHITA, A., IMAIZUMI, T., HIROOKA, Y., YOSHIDA, M., ANDO, S. & NAKAMURA, M. (1989). Biphasic forearm vascular responses to intraarterial arginine vasopressin. J. Clin. Invest., 84, 427-434.
52. TIMMERMANS, P.B. & VAN ZWIETEN, P.A. (1980). Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the alpha 2-type by B-HT 933. Eur. J. Pharmacol., 63, 199-202.
53. WACHTER, C., HEINEMANN, A., JOCIC, M. & HOLZER, P. (1995). Visceral vasodilatation and somatic vasoconstriction evoked by acid challenge of the rat gastric mucosa: diversity of mechanisms. J. Physiol., 486, 505-516.
54. WALKER, B.R., HAYNES, J. Jr., WANG, H.L. & VOELKEL, N.F. (1989). Vasopressin-induced pulmonary vasodilatation in rats. Am. J. Physiol., 257, H415-H422.
55. WIENEN, W., HAUEL, N., VAN MEEL, J.C.A., NARR, B., RIES, U. & ENTZEROTH, M. (1993). Pharmacological characterization of the novel, non-peptide angiotensin II receptor antagonist, BIBR 277. Br. J. Pharmacol., 110, 245-252.